Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs
Current Molecular Pharmacology · 2026 · 19 (1) · 61-73
DOI: 10.1016/j.cmp.2026.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Jun Peng und 7 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, J., Zhang, Y., Huang, W., Wang, W., Zeng, W., Li, W., Xiao, L., & Meng, Y. (2026). Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs. Current Molecular Pharmacology, 19(1), 61-73. https://doi.org/10.1016/j.cmp.2026.02.002
Vancouver
Peng J, Zhang Y, Huang W, Wang W, Zeng W, Li W, et al. Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs. Current Molecular Pharmacology. 2026;19(1):61-73. doi:10.1016/j.cmp.2026.02.002
BibTeX
@article{Peng2026,
author = {Peng, Jun and Zhang, Yue and Huang, Wenhui and Wang, Wei and Zeng, Wenyi and Li, Wenhan and Xiao, Linjie and Meng, Ying},
title = {Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {61--73},
doi = {10.1016/j.cmp.2026.02.002}
}
EUVIMED